Fractyl Health (GUTS) Cash from Operations (2023 - 2026)
Fractyl Health's (GUTS) quarterly Cash from Operations came in at 22477000.0 in Q1 2026, up 10.38% YoY from 20364173.37 in Q1 2025, and down 5.35% on a QoQ basis from 21336000.0 in Q4 2025.
Fractyl Health (GUTS) Cash from Operations (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Cash from Operations data on file, last reported at 22477000.0 in Q1 2026.
- Quarterly Cash from Operations rose 10.38% year-over-year to 22477000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 87726000.0 (down 11.2% YoY) and the FY2025 annual result came in at 90328000.0, down 37.86% from the prior year.
- Cash from Operations eased to 22477000.0 in Q1 2026, from 21336000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 9550000.0 in Q1 2023 to a low of 25079000.0 in Q1 2025.
- A 4-year average of 17011461.54 and a median of 18039000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2025 — Cash from Operations slumped 114.15% — and 2026, when it climbed 10.38%.
- Tracing GUTS's Cash from Operations over 4 years: stood at 10599000.0 in 2023, then slumped by 60.71% to 17034000.0 in 2024, then declined by 25.26% to 21336000.0 in 2025, then fell by 5.35% to 22477000.0 in 2026.
- The last three Cash from Operations figures came in at 22477000.0 (Q1 2026), 21336000.0 (Q4 2025), and 22714000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - | -15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.90 Mn |
| Jun 30, 2026 | -15.90 Mn |
| Mar 31, 2026 | -22.48 Mn |
| Mar 31, 2026 | -22.48 Mn |
| Dec 31, 2025 | -21.34 Mn |
| Dec 31, 2025 | -21.34 Mn |
| Sep 30, 2025 | -22.71 Mn |
| Sep 30, 2025 | -22.71 Mn |
| Jun 30, 2025 | -21.20 Mn |
| Jun 30, 2025 | -21.20 Mn |
| Mar 31, 2025 | -25.08 Mn |
| Mar 31, 2025 | -25.08 Mn |
| Dec 31, 2024 | -17.03 Mn |
| Dec 31, 2024 | -17.03 Mn |
| Sep 30, 2024 | -18.04 Mn |
| Sep 30, 2024 | -18.04 Mn |
| Jun 30, 2024 | -18.74 Mn |
| Jun 30, 2024 | -18.74 Mn |
| Mar 31, 2024 | -11.71 Mn |
| Mar 31, 2024 | -11.71 Mn |